Skip to main content

Table 5 The diagnostic validity and the optimal cut-off values of different HCC markers combination

From: Noninvasive identification of molecular biomarkers of hepatocellular carcinoma in HCV-Egyptian patients

Variables

Sensitivity

Specificity

AUC

SE

95% CI

p-value

AFP, CK-1, & GPC-3

86.4%

71.4%

0.85

0.07

0.72–0.97

0.001

AFP, CK-1, & ADAM8

77.3%

64.3%

0.83

0.07

0.69–0.96

0.001

AFP, CK-1, & HGF

77.3%

64.3%

0.80

0.07

0.66–0.95

0.003

AFP, CK-1, & DMK

81.8%

64.3%

0.83

0.07

0.69–0.97

0.001

AFP, GPC-3, & ADAM8

86.4%

64.3%

0.79

0.08

0.63–0.96

0.003

AFP, GPC3, & HGF

86.4%

71.4%

0.82

0.09

0.65–0.98

0.002

AFP, GPC3, & MDK

81.8%

78.6%

0.83

0.08

0.68–0.99

0.001

AFP, ADAM8, & HGF

81.8%

78.6%

0.81

0.08

0.65–0.96

0.002

AFP, ADAM8, & MDK

77.3%

71.4%

0.83

0.07

0.69–0.96

0.001

AFP, HGF, & MDK

81.8%

71.4%

0.79

0.09

0.62–0.95

0.004